Gut

Cost Effectiveness Of Rifaximin-α In The Reduction Of Recurrence Of Overt Hepatic Encephalopathy

http://dx.doi.org/10.1136/gutjnl-2014-307263.413

Post author By Poole C D, Conway P, Nanuwa K, Joseph B, Bannister Ch A and Currie C J
Post date 9 June 2014

Poole C D, Conway P, Nanuwa K, Joseph B, Bannister Ch A, and Currie C J. 09 Jun 2014

Poole C D

Conway P

Nanuwa K

Joseph B

Bannister Ch A

Currie C J

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Site by Create Summit